MacroGenics Inc. (MGNX) Reveals an Earnings Mystery – News Heater
Home  »  Hot Stocks   »  MacroGenics Inc. (MGNX) Reveals an Earnings Myster...

MacroGenics Inc. (MGNX) Reveals an Earnings Mystery

MacroGenics Inc. (NASDAQ:MGNX) went up by 25.22% from its latest closing price compared to the recent 1-year high of $29.16. The company’s stock price has collected 18.03% of gains in the last five trading sessions.

Is It Worth Investing in MacroGenics Inc. (NASDAQ :MGNX) Right Now?

Plus, the 36-month beta value for MGNX is at 2.22. Opinions of the stock are interesting as 9 analysts out of 11 who provided ratings for MacroGenics Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

The average price from analysts is $27.50, which is $25.45 above the current price. MGNX currently public float of 58.22M and currently shorts hold a 10.46% ratio of that float. Today, the average trading volume of MGNX was 1.01M shares.

MGNX’s Market Performance

MGNX stocks went up by 18.03% for the week, with a monthly drop of -26.15% and a quarterly performance of -67.16%, while its annual performance rate touched -86.99%. The volatility ratio for the week stands at 13.17% while the volatility levels for the past 30 days are set at 10.06% for MacroGenics Inc. The simple moving average for the period of the last 20 days is -8.41% for MGNX stocks with a simple moving average of -78.16% for the last 200 days.

Analysts’ Opinion of MGNX

Citigroup, on the other hand, stated in their research note that they expect to see MGNX reach a price target of $21, previously predicting the price at $23. The rating they have provided for MGNX stocks is “Buy” according to the report published on February 28th, 2022.

BMO Capital Markets gave a rating of “Outperform” to MGNX, setting the target price at $31 in the report published on February 11th of the current year.

MGNX Trading at -45.04% from the 50-Day Moving Average

After a stumble in the market that brought MGNX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.12% of loss for the given period.

Volatility was left at 10.06%, however, over the last 30 days, the volatility rate increased by 13.17%, as shares sank -27.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -69.20% lower at present.

During the last 5 trading sessions, MGNX rose by +18.03%, which changed the moving average for the period of 200-days by -87.66% in comparison to the 20-day moving average, which settled at $3.09. In addition, MacroGenics Inc. saw -82.06% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at MGNX starting from Karrels James, who purchase 40,000 shares at the price of $2.47 back on Jun 15. After this action, Karrels James now owns 191,776 shares of MacroGenics Inc., valued at $98,800 using the latest closing price.

BIOTECH TARGET N V, the 10% Owner of MacroGenics Inc., purchase 200,000 shares at $18.50 during a trade that took place back on Nov 19, which means that BIOTECH TARGET N V is holding 7,275,564 shares at $3,700,320 based on the most recent closing price.

Stock Fundamentals for MGNX

Current profitability levels for the company are sitting at:

  • -261.85 for the present operating margin
  • +82.04 for the gross margin

The net margin for MacroGenics Inc. stands at -260.97. Equity return is now at value -84.50, with -61.00 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.75.

Is ACM Research Inc. (ACMR) a Keeper?

ACM Research Inc. (NASDAQ:ACMR) went down by -3.29% from its latest closing price compared to the recent 1-year high of $39.71. The company’s stock price

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]